SUPPLEMENT ARTICLE Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs Geert Robaeys,1,2,3,a Jason Grebely,4,a Stefan Mauss,5 Philip Bruggmann,6 Joseph Moussalli,7,8 Andrea De

First Page		Document Content
Date: 2014-07-25 10:26:12 Protease inhibitors Antivirals Cytokines Hepatitis Viral hepatitis Hepatitis C Peginterferon alfa-2a Telaprevir Boceprevir Medicine Biology Health		SUPPLEMENT ARTICLE Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs Geert Robaeys,1,2,3,a Jason Grebely,4,a Stefan Mauss,5 Philip Bruggmann,6 Joseph Moussalli,7,8 Andrea De Add to Reading List Source URL: www.hepatitis-c-initiative.eu Download Document from Source Website File Size: 165,39 KB Share Document on Facebook

	IP followed by western blot Every step needs to be performed cold, either in the cold room or on ice!!! • Lyse cells in appropriate lysis buffer (standard buffer is 1% NP40 or Triton-X100) with protease inhibitors DocID: 1szfy - View Document
	Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). Ada DocID: 1sgtI - View Document
	June 17, 2009 Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds Damilola A. Adepegba, Department of Natural Sciences, University of Maryland DocID: 1qLnJ - View Document
	Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). Ada DocID: 1pbRe - View Document
	© 2003 Nature Publishing Group http://www.nature.com/naturebiotechnology LETTERS Discovering potent and selective reversible inhibitors of enzymes in complex proteomes DocID: 1oHMR - View Document